Inflammatory Breast Carcinoma: Pathological or Clinical Entity?

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.64, Iss.3, 2000-12, pp. : 269-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High Grade Primary Breast Lymphoma: is it a Different Clinical Entity?

By Fruchart Christophe

Breast Cancer Research and Treatment, Vol. 93, Iss. 3, 2005-10 ,pp. : 191-198

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and pathological features of glycogen-rich clear cell carcinoma of the breast

By Kuroda Hajime

Breast Cancer, Vol. 12, Iss. 3, 2005-07 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite

Cytosolic levels of TFF1/pS2 in breast cancer: their relationship with clinical–pathological parameters and their prognostic significance

By Corte Maria D. Tamargo Francisco Alvarez Ana RodrÃguez J.C. VÃ¡zquez J. SÃ¡nchez Rosario Lamelas Maria L. GonzÃ¡lez L.O. Allende Maria T. GarcÃa-MuÃ±iz J.L. Fueyo A. Vizoso F.

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 63-72

Springer Publishing Company

Access to resources Recommend Favorite

Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expression

By Barnes P.

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 173-178

Springer Publishing Company

Access to resources Recommend Favorite

Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ?

By Rakovitch Eileen

Breast Cancer Research and Treatment, Vol. 87, Iss. 3, 2004-10 ,pp. : 265-272

Springer Publishing Company

Access to resources Recommend Favorite